Ye E Huang

US Patent:

7693974, Apr 6, 2010

Filed:

Feb 6, 2004

Appl. No.:

10/773913

Inventors:

Ye Huang - San Jose CA, US
William Lawton Crowe - Olathe KS, US
Royal Dean Howell - Trimble MO, US

Assignee:

Sprint Communications Company L.P. - Overland Park KS

International Classification:

G06F 15/177

US Classification:

709223, 715736

Abstract:

A system and method for providing a graphical user interface (GUI) for network development, management, and monitoring includes a GUI front end that provides a graphical representation of a telecommunication network comprised of communication devices represented by GUI network elements. A network proxy provides a communication layer between the GUI and a network server and allows the GUI to connect to multiple instances of a network server without having to hard code the connections to the network servers. The network proxy transmits commands and messages between the network server and the GUI. The network server determines how to handle traffic in the network model, such as how to provide call setup, call routine, and call tear down. The network server transmits call routing commands and messages to the network proxy which dispatches them to the GUI. An external systems interface provides the mechanism for which the network server communicates with communication devices in an external system.

US Patent:

8588818, Nov 19, 2013

Filed:

Nov 8, 2011

Appl. No.:

13/291718

Inventors:

Ye Huang - San Ramon CA, US
Jerry Kupsh - Concord CA, US
Hugh Fletcher - Mountain View CA, US
Amir Mayblum - Walnut Creek CA, US

Assignee:

Cellco Partnership - Basking Ridge NJ

International Classification:

H04M 11/04
G08G 1/123
H04N 7/025

US Classification:

4554563, 4554041, 340989, 725 33

Abstract:

For a location-based broadcast messaging service, a broadcast server receives a broadcast request from a business application server. The broadcast request includes a message, at least one identifier for target mobile devices, and an identifier for a location. The broadcast server sends a location query including the identifier for the location to location agents associated with the target mobile devices. In response to receiving the location query, each location agent determines whether the location of the associated mobile device is within or otherwise satisfies a requirement related to the identified location. If the location of the device is within the identified location or satisfies the requirement, the location agent sends a query response to the broadcast server and receives, from the broadcast server, the message included in the broadcast request. The broadcast request can include a time-period identifier, such that the location agent determines the device location during the time-period.

US Patent:

8590057, Nov 19, 2013

Filed:

Jul 15, 2011

Appl. No.:

13/184119

Inventors:

Amir Mayblum - Walnut Creek CA, US
Ye Huang - San Ramon CA, US

Assignee:

Cellco Partnership - Basking Ridge NJ

International Classification:

H04L 9/38
H04L 9/32

US Classification:

726 28, 726 17, 726 29

Abstract:

A server may receive encryption key requests that each identify a sender of the encryption key request and at least one recipient of information that is to be encrypted with the requested encryption key. In response, an encryption key may be sent to the sender of the encryption key request. Information identifying the sender and the at least one recipient may be stored. The server may receive decryption key requests that each identify a sender of the decryption key request and a sender of encrypted information. In response, a decryption key may be sent to the sender of the decryption key request if and only if the sender of encrypted information and the sender of the decryption key request, as both identified by the information in the decryption key request, match, respectively, a sender of an encryption key request and an associated recipient, as both identified by the stored information.

US Patent:

20030071840, Apr 17, 2003

Filed:

Dec 18, 1998

Appl. No.:

09/216354

Inventors:

YE HUANG - SAN JOSE CA, US
WILLIAM LAWTON CROWE - OLATHE KS, US
ROYAL DEAN HOWELL - TRIMBLE MO, US

International Classification:

G09G005/00

US Classification:

345/736000

Abstract:

A system and method for providing a graphical user interface (GUI) for network development, management, and monitoring includes a GUI front end that provides a graphical representation of a telecommunication network comprised of communication devices represented by GUI network elements. A network proxy provides a communication layer between the GUI and a network server and allows the GUI to connect to multiple instances of a network server without having to hard code the connections to the network servers. The network proxy transmits commands and messages between the network server and the GUI. The network server determines how to handle traffic in the network model, such as how to provide call setup, call routing, and call tear down. The network server transmits call routing commands and messages to the network proxy which dispatches them to the GUI. An external systems interface provides the mechanism for which the network server communicates with communication devices in an external system.

US Patent:

20050158382, Jul 21, 2005

Filed:

Sep 24, 2004

Appl. No.:

10/949141

Inventors:

Evangeline Cruz - Hayward CA, US
Atul Ayer - Palo Alto CA, US
Brenda Pollock - Cupertino CA, US
Carmelita Garcia - Newark CA, US
Sherry Li - Cupertino CA, US
Alfredo Wong - Sunnyvale CA, US
Lawrence Hamel - Mountain View CA, US
Cheri Klein - Northbrook IL, US
Yihong Qiu - Vernon Hills IL, US
Ye Huang - Gurnee IL, US

International Classification:

A61K031/485
A61K031/16
A61K009/22

US Classification:

424468000, 514282000, 514629000

Abstract:

Sustained release dosage forms for twice daily oral dosing to a human patient for providing relief from pain are provided. The sustained release dosage form comprises an immediate release component and a sustained release component, wherein the immediate release component and the sustained release component collectively contain a therapeutically effective amount of an opioid analgesic and a therapeutically effective amount of nonopioid analgesic. In a preferred embodiment, the nonopioid analgesic is acetaminophen and the opioid analgesic is hydrocodone and pharmaceutically acceptable salts thereof, and in preferred embodiments, the pharmaceutically acceptable salt is bitartrate. The dosage forms produce plasma profiles in a patient characterized by a Cmax for hydrocodone of between about 0.6 ng/mL/mg to about 1.4 ng/mL/mg and an AUC for hydrocodone of between about 9.1 ng*hr/mL/mg to about 19.9 ng*hr/mL/mg (per mg hydrocodone bitartrate administered) and a Cmax for acetaminophen of between about 2.8 ng/mL/mg and 7.9 ng/mL/mg and an AUC for acetaminophen of between about 28.6 ng*hr/mL/mg and about 59.1 ng*hr/mL/mg (per mg acetaminophen administered) after a single dose.

US Patent:

20060251721, Nov 9, 2006

Filed:

Jun 30, 2006

Appl. No.:

11/480124

Inventors:

Evangeline Cruz - Hayward CA, US
Atul Ayer - Palo Alto CA, US
Brenda Pollock - Cupertino CA, US
Carmelita Garcia - Newark CA, US
Sherry Li - Cupertino CA, US
Alfredo Wong - Sunnyvale CA, US
Lawrence Hamel - Mountain View CA, US
Cheri Klein - Northbrook IL, US
Yihong Qiu - Vernon Hills IL, US
Ye Huang - Gurnee IL, US

International Classification:

A61K 31/485
A61K 9/22
A61K 31/16

US Classification:

424468000, 514282000, 514625000

Abstract:

Sustained release dosage forms for twice daily oral dosing to a human patient for providing relief from pain are provided. The sustained release dosage form comprises an immediate release component and a sustained release component, wherein the immediate release component and the sustained release component collectively contain a therapeutically effective amount of an opioid analgesic and a therapeutically effective amount of nonopioid analgesic. In a preferred embodiment, the nonopioid analgesic is acetaminophen and the opioid analgesic is hydrocodone and pharmaceutically acceptable salts thereof, and in preferred embodiments, the pharmaceutically acceptable salt is bitartrate. The dosage forms produce plasma profiles in a patient characterized by a Cmax for hydrocodone of between about 0.6 ng/mL/mg to about 1.4 ng/mL/mg and an AUC for hydrocodone of between about 9.1 ng*hr/mL/mg to about 19.9 ng*hr/mL/mg (per mg hydrocodone bitartrate administered) and a Cmax for acetaminophen of between about 2.8 ng/mL/mg and 7.9 ng/mL/mg and an AUC for acetaminophen of between about 28.6 ng*hr/mL/mg and about 59.1 ng*hr/mL/mg (per mg acetaminophen administered) after a single dose.

US Patent:

20100151866, Jun 17, 2010

Filed:

Dec 16, 2008

Appl. No.:

12/335879

Inventors:

Sergei Karpov - Concord CA, US
Ye Huang - San Ramon CA, US

Assignee:

VERIZON CORPORATE SERVICES GROUP INC. - Basking Ridge NJ

International Classification:

H04W 40/00

US Classification:

455445

Abstract:

An approach is provided for routing inter-carrier messaging traffic between a messaging application on a first carrier and a messaging device on a second carrier using a carrier-assigned identifier.

US Patent:

20100221293, Sep 2, 2010

Filed:

Mar 2, 2010

Appl. No.:

12/716086

Inventors:

Evangeline Cruz - Hayward CA, US
Atul D. Ayer - Palo Alto CA, US
Brenda J. Pollock - Cupertino CA, US
Carmelita Garcia - Newark CA, US
Sherry Li - Cupertino CA, US
Alfredo M. Wong - Sunnyvale CA, US
Lawrence G. Hamel - Mountain View CA, US
Cheri Enders Klein - Northbrook IL, US
Yihong Qiu - Vernon Hills IL, US
Ye Huang - Gurnee IL, US

International Classification:

A61K 31/485
A61K 9/00
A61P 25/00

US Classification:

424400, 514282

Abstract:

Sustained release dosage forms for twice daily oral dosing to a human patient for providing relief from pain are provided. The sustained release dosage form comprises an immediate release component and a sustained release component, wherein the immediate release component and the sustained release component collectively contain a therapeutically effective amount of an opioid analgesic and a therapeutically effective amount of nonopioid analgesic. In a preferred embodiment, the nonopioid analgesic is acetaminophen and the opioid analgesic is hydrocodone and pharmaceutically acceptable salts thereof, and in preferred embodiments, the pharmaceutically acceptable salt is bitartrate. The dosage forms produce plasma profiles in a patient characterized by a Cmax for hydrocodone of between about 0.6 ng/mL/mg to about 1.4 ng/mL/mg and an AUC for hydrocodone of between about 9.1 ng*hr/mL/mg to about 19.9 ng*hr/mL/mg (per mg hydrocodone bitartrate administered) and a Cmax for acetaminophen of between about 2.8 ng/mL/mg and 7.9 ng/mL/mg and an AUC for acetaminophen of between about 28.6 ng*hr/mL/mg and about 59.1 ng*hr/mL/mg (per mg acetaminophen administered) after a single dose.